GSK3β (Glycogen Synthase Kinase 3 beta) is a serine/threonine kinase encoded by the GSK3B gene that plays critical roles in neuronal function, synaptic plasticity, and neurodegenerative disease pathogenesis. Neurons expressing high levels of GSK3β are particularly vulnerable to dysfunction in Alzheimer's disease, Parkinson's disease, and other neurological disorders .
- Substrate specificity: Phosphorylates over 100 substrates
- Activity: Constitutively active in resting cells
- Regulation: Inhibited by Akt, PKA, and insulin signaling
- Isoforms: GSK3α (51 kDa) and GSK3β (47 kDa) in mammals
- Tau protein: Phosphorylation at multiple sites (Ser199, Ser202, Thr205, Ser396, Ser404)
- β-catenin: Destruction complex regulation
- CREB: Transcription factor phosphorylation
- AMPA receptor subunits: Synaptic plasticity
- NMDA receptor subunits: Calcium flux regulation
- Dynamin-1: Synaptic vesicle endocytosis
GSK3β is expressed throughout neurons but concentrated in:
- Dendritic shafts: Associated with dendritic spines
- Axon initial segment: Regulation of action potential initiation
- Synaptic vesicles: Pre-synaptic terminals
- Mitochondria: Energy metabolism regulation
GSK3β regulates both long-term potentiation (LTP) and depression (LTD):
- LTP: Transient activation required for memory formation
- LTD: Persistent activation leads to synaptic weakening
- Balances structural plasticity of dendritic spines
- Axon specification and polarity
- Neurite outgrowth and branching
- Synapse formation and maturation
- Mitochondrial function regulation
- Glucose homeostasis
- Response to metabolic stress
- GSK3β activity oscillates with circadian cycle
- Phosphorylates circadian clock proteins (PER2, CRY1)
Tau Pathology:
- Hyperactive GSK3β hyperphosphorylates tau
- Creates neurotoxic tau species
- Promotes NFT (neurofibrillary tangle) formation
- Correlates with cognitive decline severity
Amyloid Interaction:
- Amyloid-beta increases GSK3β activity
- Creates feed-forward loop of pathology
- Aβ-induced synaptic loss partially mediated by GSK3β
Synaptic Dysfunction:
- Impairs LTP and memory consolidation
- Reduces spine density
- Alters NMDA/AMPA receptor function
α-Synuclein Phosphorylation:
- GSK3β phosphorylates α-synuclein at Ser129
- Promotes aggregation and toxicity
- Lewy bodies contain phosphorylated α-synuclein
Mitochondrial Dysfunction:
- Phosphorylates dynamin-1 like protein
- Impairs mitophagy
- Contributes to energy failure
Dopaminergic Vulnerability:
- GSK3β activity higher in substantia nigra
- Makes neurons more susceptible to toxins
- Linked to sporadic PD pathogenesis
- GSK3β is a major lithium target
- Lithium inhibits GSK3β to exert therapeutic effects
- SNP in GSK3B promoter affects disease risk
- Altered GSK3β signaling in prefrontal cortex
-关联 with cognitive deficits
- Dysregulated downstream pathways
Neurons with high GSK3β activity are vulnerable because:
- Tau hyperphosphorylation: Creates toxic oligomers
- Synaptic dysfunction: Impairs communication
- Energy failure: Mitochondrial dysfunction
- Oxidative stress: Increased ROS production
- Lithium: Direct inhibitor, used in bipolar disorder
- Tideglusib: Non-ATP competitive inhibitor in trials
- CHIR99021: Selective small molecule inhibitor
- Natural compounds: Flavonoids, curcumin derivatives
- Essential functions in normal neurons
- Broad substrate specificity
- Peripheral side effects
- Blood-brain barrier penetration
- Aβ-targeted therapies + GSK3β inhibitors
- Tau-targeted approaches
- Neuroprotective strategies